ANGELINE WILLIAMS: Open Payments
NPI 1992365902 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 19 payments from 14 companies in 2025. Trend: 2023 $1,419 · 2024 $1,701 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $383 |
| Organogenesis Inc. | 1 | $174 |
| Alexion Pharmaceuticals, Inc. | 2 | $127 |
| GENZYME CORPORATION | 1 | $127 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Sage Therapeutics, LLC | 1 | $99 |
| Madrigal Pharmaceuticals | 1 | $85 |
| Insmed, Inc. | 1 | $72 |
| ABBVIE INC. | 3 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $70 |
Products named: APLIGRAF, STRENSIQ, KEVZARA, NEFFY, REZDIFFRA, Arikayce, RINVOQ, TREMFYA.
Industry payments across MD — which companies pay providers there.
